Postpartum Anxiety: Symptoms, Causes, Duration and Treatment

Postpartum anxiety is persistent, hard-to-control worry, fear or panic that begins or worsens after childbirth and interferes with daily life. It is common and often overlaps with postpartum depression: a 2017 meta-analysis of 102 studies covering 221,974 women in 34 countries put the share of mothers with anxiety symptoms 1 to 24 weeks after birth at 15.0%^[1].

Rates by year, state and demographic group are on the postpartum anxiety statistics page and the postpartum population hub. This article covers what the condition looks like, how it differs from depression, how long it lasts and what treatment trials show.

The DSM-5 has no separate diagnosis called postpartum anxiety^[6]. Its "with peripartum onset" specifier is attached to mood episodes, such as depression, and covers onset only through 4 weeks after delivery^[6]. Clinicians instead diagnose the specific condition present, such as generalized anxiety disorder, panic disorder or obsessive-compulsive disorder.

That is why research reports two kinds of figures. In the same meta-analysis, 9.9% of mothers met criteria for any anxiety disorder between 1 and 24 weeks postpartum, and 5.7% met criteria for generalized anxiety disorder^[1].

A central difficulty in recognizing postpartum anxiety is separating it from the ordinary worry of caring for a newborn. A 2015 clinical review named the difficulty of telling normal from pathological worry as a major barrier to diagnosing perinatal generalized anxiety disorder^[7].

NIMH lists these among the symptoms of perinatal depression, and several are also core features of anxiety^[8]:

• A persistently anxious mood most of the day, nearly every day
• Irritability, frustration or restlessness, including trouble sitting still
• Difficulty sleeping even when the baby is asleep
• Difficulty concentrating, remembering or making decisions
• Persistent doubts about the ability to care for the baby
• Aches, headaches or digestive problems without a clear physical cause

Physical symptoms complicate the picture after birth, when fatigue and body changes are expected. A 2014 validation study noted that physical and somatic symptoms make anxiety harder to distinguish from depression during pregnancy and the postpartum period^[9].

Intrusive thoughts about the baby

Unwanted, intrusive thoughts of harm coming to the infant are common. In a prospective study of 763 women in British Columbia, 95.8% reported postpartum thoughts of accidental harm and 53.9% reported unwanted thoughts of intentional harm^[3].

The most common accidental-harm thoughts involved the baby suffocating or dying of sudden infant death syndrome, and the most common intentional-harm thoughts involved neglect^[3]. Distress peaked in the first 8 weeks, when over 40% of participants rated it moderate or extreme^[3].

Most participants did not report clinically significant symptoms, and the authors described the thoughts as normative and typically self-resolving^[3]. When intrusive thoughts persist, drive repeated checking or avoidance, and impair daily life, clinicians assess for obsessive-compulsive disorder.

Postpartum psychosis is a separate condition. It involves delusions, hallucinations, mania, paranoia or confusion, and NIMH classifies it as a psychiatric emergency that requires hospitalization^[8].

The baby blues are mild, short-lasting mood changes, including worry, unhappiness and exhaustion, that many women experience in the first 2 weeks after giving birth^[8]. NIMH describes mood changes or feelings of anxiety that are severe or last longer than 2 weeks after childbirth as possible signs of postpartum depression rather than the blues^[8].

The overlap starts with symptoms. NIMH's list for perinatal depression includes an anxious mood, restlessness, irritability and sleep problems^[8]. The features on that list that point to depression rather than anxiety are persistent sadness or emptiness, hopelessness, guilt and loss of interest in activities^[8].

The two frequently occur together. Between 1 and 24 weeks postpartum, 8.2% of mothers had both anxiety symptoms and mild-to-severe depressive symptoms, and 4.2% had a clinical diagnosis of both conditions, according to a 2017 meta-analysis of 66 studies and 162,120 women^[4].

In U.S. claims data, a combined anxiety and depression diagnosis was recorded for 18.0 per 1,000 women within a year of giving birth^[2]. Treatment for the depressive side is covered in postpartum depression treatment.

Postpartum anxiety can surface soon after delivery or months later. In the U.S. claims study, 9,490 of 84,984 new postpartum anxiety diagnoses were made in the first month after birth and 75,494 between 1 month and 1 year^[2]. Diagnosis dates lag symptom onset, so these figures show when care was recorded, not exactly when symptoms began.

For a meaningful share of mothers, symptoms persist. In a population-based cohort of 522 mothers near Vancouver, 12.6% had elevated anxiety at week 1 or week 4 that was still present at week 8 postpartum^[10].

Intrusive thoughts follow a shorter arc: in the 2024 cohort, most decreased in frequency or resolved completely by 6 months postpartum^[3]. The studies cited here stop at 8 weeks^[10], 24 weeks^[1] or 12 months^[2], so they do not show how long untreated postpartum anxiety persists beyond the first year.

Diagnoses have become more frequent. Among commercially insured U.S. women, the rate of new postpartum anxiety diagnoses rose from 30.8 per 1,000 in 2008 to 122.9 per 1,000 in 2021^[2]. A rise in claims can reflect more screening and diagnosis as well as more illness, and claims data cannot separate the two.

Studies identify risk factors rather than a single cause. A 2025 systematic review of 39 reports covering 40,238 people in Australia, Europe and North America sorted them into seven categories, from psychopathology and personality to infant characteristics and postpartum experiences^[11].

The most frequently supported risk factors were a past history of depression, current depression, a past history of anxiety and low social support^[11].

Stress and partner support show up early. In the Vancouver cohort, each 1-standard-deviation increase in perceived stress at 1 week postpartum was associated with 3.74 times the odds of sustained anxiety, while higher partner support was associated with lower odds (odds ratio 0.59)^[10].

U.S. claims data add birth and health factors. New anxiety diagnosed 1 to 12 months after birth was associated with younger age, earlier gestational age at delivery, cesarean delivery, sleep disorders during pregnancy or early postpartum, severe maternal morbidity and newborn complications^[2].

All of these findings come from observational studies. They identify who is at higher risk, not what causes the condition.

The American College of Obstetricians and Gynecologists' 2023 Clinical Practice Guideline No. 4 includes recommendations on screening and diagnosis of perinatal anxiety alongside depression, bipolar disorder, postpartum psychosis and suicidality^[12]. It covers conditions that begin in pregnancy or the first year postpartum, as well as earlier conditions that worsen during that time^[12].

Screening uses short questionnaires, with a clinical interview to confirm a diagnosis. Two common instruments are the 7-item Generalized Anxiety Disorder scale (GAD-7) and the Edinburgh Postnatal Depression Scale (EPDS), including its 3-item anxiety subscale, the EPDS-3A^[9].

Their accuracy is moderate. Among 240 pregnant and postpartum women referred for psychiatric consultation, the GAD-7 at a cutoff score of 13 had 61.3% sensitivity and 72.7% specificity for generalized anxiety disorder^[9]. It identified the disorder more accurately than the EPDS or EPDS-3A when depression was also present^[9].

No screening tool designed specifically for perinatal generalized anxiety disorder existed as of a 2015 clinical review^[7]. Screening results are a starting point; a diagnosis rests on a clinician's assessment of which disorder, if any, fits the symptoms.

Treatment follows severity. A 2015 clinical review described cognitive behavioral therapy (CBT), relaxation and mindfulness therapy as indicated for mild perinatal generalized anxiety disorder, and medication and CBT, alone or combined, for moderate to severe illness^[7].

The trial evidence is strongest for CBT. A 2026 network meta-analysis of 78 randomized trials with 11,345 participants found CBT reduced perinatal anxiety more than usual care (standardized mean difference -0.54), with moderate confidence in the evidence^[5].

Behavioral therapy and mindfulness-based interventions also outperformed usual care for anxiety in the short term, but on low or very low certainty evidence, and only behavioral therapy showed a sustained effect^[5]. More on how these therapies work is in therapy for anxiety.

On medication, the 2015 review listed SSRIs and SNRIs as first-line treatment for anxiety disorders, with benzodiazepines an option for short-term use^[7]. It noted that no psychotropic drug was approved by the FDA for use in pregnancy or the postpartum period, so prescribing was off-label and based on weighing benefit against risk^[7].

The two drugs the FDA has since approved for a postpartum condition, brexanolone and zuranolone, are indicated for postpartum depression^[8]. NIMH advises pregnant or nursing women to tell their provider so the baby's exposure to medication can be minimized and risks and benefits weighed^[8]. Drug classes are compared in anxiety medication.

The National Maternal Mental Health Hotline, 1-833-852-6262 (1-833-9-TLC-MAMA), offers free, confidential support by call or text 24 hours a day, 7 days a week, in English and Spanish^[8]. For thoughts of suicide, the 988 Suicide & Crisis Lifeline answers calls and texts at 988^[8].